Hot stocks to watch this afternoon: GPRO, HAS, MU >>> READ MORE

VRTX

Recent Articles

Vertex Pharmaceuticals (VRTX) a Buy on Solid Earnings Momentum

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is classified as a member of the 345 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. VRTX has a market value of $38.8 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for VRTX puts it 40 among the 345 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 133 among the 782 companies in the sector, and number 983 in the nearly 5,000 company Portfolio Grader universe. More 

Vertex Pharmaceuticals (VRTX) a Buy on Superior Earnings Momentum

The current recommendation of Buy for Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is derived using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. VRTX has maintained this ranking for 3 months. More 

Stock of Vertex Pharmaceuticals (VRTX) Maintains Buy Recommendation

The current recommendation of Buy for Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. VRTX has maintained this ranking for 2 months. More 

Top 10 Best Stocks to Buy in the S&P 500 Through Q3

The best stocks to buy right now in the S&P 500 through the third quarter thrive on the 'Trump trade' and strong fundamentals. More 

Stock of Vertex Pharmaceuticals (VRTX) Maintains Buy Recommendation

The current recommendation of Buy for Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. VRTX has maintained this ranking for 2 months. More 

4 Biotech Stocks That More Than Doubled This Year

The biotech sector has been witnessing an uptrend this year with impressive performance in both the quarters. Shares of quite a few companies have more than dou... More 

3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock

It has been a banner year for Vertex -- the company’s R&D efforts have paid off in a big way. Yet there are still major issues for VRTX stock. More